Is ‘GOLD’ standard for the management of COPD in clinical practice?
Summary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations...
| Main Author: | Barbara Yawn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2012-11-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | http://drugsincontext.com/individual/is-gold-standard-for-the-management-of-copd-in-clinical-practice |
Similar Items
-
A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol
by: Buhl R, et al.
Published: (2020-10-01) -
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
by: Christian Vogelberg, et al.
Published: (2020-01-01) -
Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
by: Bruno Balbi
Published: (2015-08-01) -
An update on chronic obstructive pulmonary disease
by: Natalie Schellack, et al.
Published: (2016-05-01) -
Clinical and economic evaluation of using fixed dose dual bronchodilator combination tiotropiumolodaterol in patients with chronic obstructive pulmonary disease
by: S. K. Zyryanov, et al.
Published: (2018-04-01)